Honest sales agency, price of Tarceva in India, marketing of Tarceva in India

r Our company promises: Integrity, genuine products, conscience medicines, cash on delivery

, r Consultation phone number:
< : , rbb br )< bb br )

, r Manager Liu:

, r Beijing Chengxin Pharmaceutical:

, r Beijing Chengxin Pharmaceutical sells genuine Indian products Tarceva India restarted production in March 2016. It is produced by India's largest oncology drug company. Production was suspended once before. This time, the copyright issue was resolved and production was restarted. Below is an introduction to Tarceva!

, r ＊The latest biological targeted therapy drugs for lung cancer

, r ＊Clinical studies have confirmed that targeted drugs can significantly prolong the survival of lung cancer patients. Therapeutic drugs

, r [Drug name]

, r Trade name: Tarceva

, r []Common name: salt erlotinib tablets

, r English trade name:

, r English common name: b

, r Molecular structure name: Erlotinib salt tablets

, r Chemical name:

, r ( Ethynyl phenyl), bis(methoxyethoxy)quinolineamine salt

, r Chemical structural formula:

, r Molecular formula

, r Molecular weight:

, r [Ingredients] Each tablet contains erlotinib (in the form of erlotinib salt)

, r [Properties] Round biconvex white coated tablets.

, r [Mechanism of action]

, r The anti-tumor mechanism of r is mainly to inhibit the intracellular expression of epidermal growth factor (R) tyrosine kinase Phosphorylation.

, r [Pharmacokinetics]

, r r% absorbed after oral administration, half-life is about hours, and is mainly eliminated by metabolism. The bioavailability of r after oral administration is approximately %, and peak plasma concentration is reached after several hours. Pharmacokinetic analysis of the patient treated with a single drug r showed that it took days to reach stable blood concentration. The patient's age, weight, and gender had no significant relationship with the clearance rate of the drug. Smoking can increase the clearance rate of the drug by %.

, r [Indications]

, r rUsed for locally advanced or metastatic non-small cells that have failed two or more chemotherapy regimens Third-line treatment of lung cancer.

, r [Contraindications] It is prohibited for those who are allergic to this product and its ingredients.

, r [Adverse reactions]

, r The most common adverse reactions are rash and diarrhea, and the incidence rates of rash and diarrhea are respectively % and %, the median onset time of rash is days, and the median onset time of diarrhea is days.

, r Adverse reactions with an incidence rate greater than % include: rash, diarrhea, decreased appetite, fatigue, difficulty breathing, cough, nausea, infection, vomiting, stomatitis, itching, dry skin, conjunctivitis, keratoconjunctivitis, abdominal pain.